A team of researchers led by Professor Young S. Park at Unist’s Department of Chemistry has achieved a significant breakthrough in the field of organic semiconductors. Their successful synthesis and characterization of a novel molecule called “BNBN anthracene” has opened up new possibilities for the development of advanced electronic devices.

The new R21/Matrix-MTM malaria vaccine developed by the University of Oxford and the Serum Institute of India has received prequalification status by the World Health Organization. With this approval, the vaccine can now be accessed by affected patients.

Researchers have developed two LEDs that emit different wavelengths of blue light. One LED is designed for daytime use while the other one is for evening use. An experiment showcased that volunteers experienced increased nighttime melatonin levels by 12.2 % and reduced daytime melatonin by 21.9 % compared to consistent conventional LED exposure.

A team of microbiologists from Goethe University Frankfurt has succeeded in using bacteria for the controlled storage and release of hydrogen. This is an important step in the search for carbon-neutral energy sources in the interest of climate protection.

Sanofi and Google announced that they plan to establish a new virtual Innovation Lab. The partners aim to radically transform how future medicines and health services are delivered by tapping into the power of emerging data technologies.

Tecan has introduced its new Frida Reader which is capable of eliminating nucleic acid sample loss. This unique solution further expands the firm’s portfolio of workflow automation solutions and reagents.

Researchers examined the links between childhood diet and arterial stiffness in adolescence and found out that eating a diet high in calories, fat and sugar, and low in fibre at a young age was related with stiffer arteries in adolescence.

Researchers are making use of an AI-enabled wearable device to capture their patient’s physical actions over long periods of time. The data from this wearable will help researchers to understand the effect of new drugs on these patients which are suffering from the Parkinson’s disease.

Forever chemicals i.e. per- and polyfluoroalkyl substances (PFAS) are even found in remote places such as the Arctic Ocean. A study has found that the PFAS are not confined to this water body and instead exports these forever chemicals to the North Atlantic Ocean.

The University of Oxford has launched a new clinical trial to test the Chadox1 Nipahb vaccine against the Nipah Virus. Currently, there are no approved vaccines or treatments for the disease.